Company:  MARIZYME INC (MRZM)
Form Type:  10-K
Filing Date:  4/15/2021 
CIK:  0001413754 
Address:  555 HERITAGE DRIVE
SUITE 205
 
City, State, Zip:  JUPITER, Florida 33458 
Telephone:  561-935-9955 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.80  
Change: 
0.30 (20.00%)  
Trade Time: 
Sep 22  
Market Cap: 
$65.06M
Trade MRZM now with 

© 2021  
Description of Business
We are a Nevada corporation originally incorporated on March 20, 2007, under the name SWAV Enterprises, Ltd. On September 6, 2010, we changed our name to GBS Enterprises Incorporated and from 2010 to September 2018 we were in the software products and advisory services business for email and instant messaging applications. We divested that business between December 2016 and September 2018 and, since that time, we have begun to focus on the acquisition of life science technologies. We changed our name to Marizyme, Inc. on March 21, 2018, to reflect our new life sciences focus. Our common stock is currently quoted on the OTC Markets' QB tier under the symbol "MRZM." We may also examine our options with respect to the listing of our common stock on the Nasdaq Stock market or the NYSE. In the second half of 2018, we acquired the protease-based therapeutic platform called Krillase® from ACB Holding AB.
Register and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. BUSINESS
      ITEM 1A. RISK FACTORS
        Risks Related to Liquidity and Capital Resources
      ITEM 1B. UNRESOLVED STAFF COMMENTS
      ITEM 2. PROPERTIES
      ITEM 3. LEGAL PROCEEDINGS
      ITEM 4. MINE SAFETY DISCLOSURES
    PART II
      ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      ITEM 6. SELECTED FINANCIAL DATA
      ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Results of Operations
      ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
        Report of Independent Registered Public Accounting Firm
        REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to the Consolidated Financial Statements
          NOTE 12 - SUBSEQUENT EVENTS
      ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      ITEM 9A. CONTROLS AND PROCEDURES
      ITEM 9B. OTHER INFORMATION
    PART III
      ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
        NAME AND TITLE
      ITEM 11. EXECUTIVE COMPENSATION
        COMPENSATION TABLE
        OPTIONS AGGREGATE
      ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND ...
        BENEFICIAL OWNERS
      ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND ...
      ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
    PART IV
      ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
    SIGNATURES
  EXHIBIT 10.4
  EXHIBIT 10.5
  EXHIBIT 10.6
  EXHIBIT 10.7
  EXHIBIT 10.8
  EXHIBIT 10.9
  EXHIBIT 10.10
  EXHIBIT 10.11
  EXHIBIT 10.12
  EXHIBIT 21
  EXHIBIT 31.1
    CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFIER
  EXHIBIT 32.1
    CERTIFICATION OF
  EXHIBIT 32.2
    CERTIFICATION OF